Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
643 | 3133 | 42.0 | 78% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ROLIPRAM | Author keyword | 198 | 56% | 8% | 244 |
2 | PDE4 | Author keyword | 147 | 70% | 4% | 122 |
3 | PHOSPHODIESTERASE | Author keyword | 115 | 27% | 12% | 369 |
4 | PDE10A | Author keyword | 102 | 89% | 2% | 47 |
5 | PDE4 INHIBITOR | Author keyword | 59 | 71% | 2% | 48 |
6 | PHOSPHODIESTERASE 4 | Author keyword | 58 | 58% | 2% | 66 |
7 | ROFLUMILAST | Author keyword | 44 | 54% | 2% | 56 |
8 | PDE7 | Author keyword | 35 | 86% | 1% | 18 |
9 | CYCLIC NUCLEOTIDE PHOSPHODIESTERASES | Author keyword | 35 | 47% | 2% | 55 |
10 | PHOSPHODIESTERASE 10A | Author keyword | 27 | 83% | 0% | 15 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ROLIPRAM | 198 | 56% | 8% | 244 | Search ROLIPRAM | Search ROLIPRAM |
2 | PDE4 | 147 | 70% | 4% | 122 | Search PDE4 | Search PDE4 |
3 | PHOSPHODIESTERASE | 115 | 27% | 12% | 369 | Search PHOSPHODIESTERASE | Search PHOSPHODIESTERASE |
4 | PDE10A | 102 | 89% | 2% | 47 | Search PDE10A | Search PDE10A |
5 | PDE4 INHIBITOR | 59 | 71% | 2% | 48 | Search PDE4+INHIBITOR | Search PDE4+INHIBITOR |
6 | PHOSPHODIESTERASE 4 | 58 | 58% | 2% | 66 | Search PHOSPHODIESTERASE+4 | Search PHOSPHODIESTERASE+4 |
7 | ROFLUMILAST | 44 | 54% | 2% | 56 | Search ROFLUMILAST | Search ROFLUMILAST |
8 | PDE7 | 35 | 86% | 1% | 18 | Search PDE7 | Search PDE7 |
9 | CYCLIC NUCLEOTIDE PHOSPHODIESTERASES | 35 | 47% | 2% | 55 | Search CYCLIC+NUCLEOTIDE+PHOSPHODIESTERASES | Search CYCLIC+NUCLEOTIDE+PHOSPHODIESTERASES |
10 | PHOSPHODIESTERASE 10A | 27 | 83% | 0% | 15 | Search PHOSPHODIESTERASE+10A | Search PHOSPHODIESTERASE+10A |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYCLIC NUCLEOTIDE PHOSPHODIESTERASES | 425 | 43% | 24% | 756 |
2 | CAMP SPECIFIC PHOSPHODIESTERASE | 324 | 73% | 8% | 247 |
3 | AMP SPECIFIC PHOSPHODIESTERASE | 261 | 95% | 3% | 89 |
4 | ROLIPRAM | 261 | 66% | 8% | 245 |
5 | AMP PHOSPHODIESTERASE | 149 | 64% | 5% | 146 |
6 | PDE4 INHIBITORS | 130 | 71% | 3% | 104 |
7 | CAMP PHOSPHODIESTERASE | 93 | 51% | 4% | 130 |
8 | STRIATUM ENRICHED PHOSPHODIESTERASE | 91 | 89% | 1% | 41 |
9 | AFFINITY ROLIPRAM BINDING | 85 | 100% | 1% | 26 |
10 | PDE10A | 83 | 84% | 1% | 46 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ADVANCES IN CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 3 | 14% | 1% | 19 |
2 | ADVANCES IN SECOND MESSENGER AND PHOSPHOPROTEIN RESEARCH | 2 | 12% | 1% | 19 |
3 | JOURNAL OF CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 2 | 11% | 0% | 13 |
4 | SECOND MESSENGERS AND PHOSPHOPROTEINS | 1 | 13% | 0% | 8 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use | 2006 | 698 | 246 | 72% |
Advances in targeting cyclic nucleotide phosphodiesterases | 2014 | 39 | 244 | 58% |
Biochemistry and physiology of cyclic nucleotide Phosphocliesterases: Essential components in cyclic nucleotide signaling | 2007 | 471 | 170 | 54% |
Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer's Disease: A Translational Overview | 2015 | 3 | 128 | 59% |
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents | 2006 | 399 | 334 | 72% |
Overview of PDEs and their regulation | 2007 | 265 | 168 | 85% |
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions | 2011 | 122 | 397 | 60% |
CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES - FUNCTIONAL IMPLICATIONS OF MULTIPLE ISOFORMS | 1995 | 1275 | 136 | 54% |
PDE4 inhibitors: current status | 2008 | 147 | 77 | 79% |
PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization | 2003 | 419 | 120 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACOMETR PHARMACOKINET | 13 | 71% | 0.3% | 10 |
2 | MOL PHARMACOL GRP | 8 | 15% | 1.7% | 53 |
3 | BEHAV MED PSYCHIAT | 5 | 17% | 0.8% | 26 |
4 | PULM CRIT CARE MED BRANCH | 5 | 13% | 1.1% | 33 |
5 | SACKLER PULM PHARMACOL | 3 | 12% | 0.8% | 26 |
6 | SMALL MOL CHEM | 3 | 43% | 0.2% | 6 |
7 | MATERNITE PORT ROYAL COCHIN | 3 | 100% | 0.1% | 3 |
8 | TOXICOL PHARM CHEM | 3 | 100% | 0.1% | 3 |
9 | F NES S | 3 | 31% | 0.3% | 8 |
10 | BIOCHEM D DEN | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000155537 | PDE 5 INHIBITION//PDE5//PHOSPHODIESTERASE 5 |
2 | 0.0000118099 | IBUDILAST//CAS 50847 11 5//221 MIYAMA |
3 | 0.0000092132 | GRAVIN//AKAP//A KINASE ANCHORING PROTEIN |
4 | 0.0000085657 | DOXOFYLLINE//ENPROFYLLINE//3H IMIDAZO4 5 CQUINOLIN 45H ONE |
5 | 0.0000072172 | TYPE II CGMP DEPENDENT PROTEIN KINASE//CGMP DEPENDENT PROTEIN KINASE//CANC MOL BIOL SECT |
6 | 0.0000059915 | 1 2 3 4 TETRAHYDROPYRAZINO1 2 AINDOLES//BENZOFUROPYRIDINE//IODOLACTONISATION |
7 | 0.0000058518 | ENOXIMONE//AMRINONE//MILRINONE |
8 | 0.0000056108 | CILOSTAZOL//CLIN PHARMACOKINET PHARMACODYNAM METAB//CAS 73963 72 1 |
9 | 0.0000047416 | BIOQUIM ENVELHECIMENTO DOENCAS CORRELACIONA//NPPG//BIOQUIM METABOL |
10 | 0.0000038615 | DRUG INDUCED VASCULAR INJURY//STEROID RESPONSIVE MENINGITIS ARTERITIS//CNS IMMUNE RESPONSE |